Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature.
about
Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.A Resident's Perspective of Ovarian Cancer.Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis.Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients.Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkersPrognosis and conditional disease-free survival among patients with ovarian cancerHuman xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.Potential markers for detection and monitoring of ovarian cancer.Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.Cancers Screening in an Asymptomatic Population by Using Multiple Tumour MarkersHE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective StudyThe added value of circulating tumor cells examination in ovarian cancer staging.Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survivalAccumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas.Evaluation of Preoperative Serum Levels of CA 125 and Expression of p53 in Ovarian Neoplasms: A Prospective Clinicopathological Study in a Tertiary Care Hospital.Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum-based adjuvant chemotherapy.Identification of O-glycosylated proteins that are aberrantly excreted in the urine of patients with early stage ovarian cancer.High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer.Dual detection of cancer biomarker CA125 using absorbance and electrochemical methods.Molecular Imaging of Ovarian CancerPlasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer.Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis.Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.Can mid-infrared biomedical spectroscopy of cells, fluids and tissue aid improvements in cancer survival? A patient paradigm.microRNA and Ovarian Cancer.Biological roles of glycans.CA-125: an inaccurate surveillance tool immediately after cytoreductive surgery and hyperthermic intraoperative chemotherapy (CRS-HIPEC)?Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancerDetection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer.Recreational physical activity and survival in African-American women with ovarian cancer.High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism.A joint model based on longitudinal CA125 in ovarian cancer to predict recurrence.Evaluation of the Time-Varying Effect of Prognostic Factors on Survival in Ovarian Cancer.
P2860
Q33762042-7C5D2826-B866-4867-AF97-E30C41167FC5Q33850471-E46FB93E-2643-4FED-B9B8-D26165D323E6Q34026088-F4B79AA0-77DD-4E2D-9DC8-0E15B474A99CQ34324630-29EE71D7-4599-4A90-A244-8E77E3C7D0E9Q34412873-2E669740-A2E0-4159-A260-576F21FED38FQ34692286-2313FC40-DA52-41D7-87C7-0583339942BCQ34900010-00B073D0-283C-429F-8C76-129D38F20860Q34960174-1B7FDE24-1B19-4679-8851-5C098CA5EB00Q35091615-D0D6330D-FDA4-4DF4-920B-447520AAFA98Q35916069-8D33F838-F2C3-4A7F-9785-B3FA387B0F2AQ36060534-47F8ED94-AB6B-4C55-A133-F8FC9F7F36A5Q36063865-F295DC5F-433E-45FD-BA7A-6FCFF276490FQ36226142-C960DA47-060A-40E0-98A5-911CDE3F77D6Q36229421-DC98C990-1889-4920-B8B8-ECE97F8A8A89Q36420164-D7632E86-C7AA-4E01-B384-5A4F5F19F209Q36546798-45DF218A-6158-4559-B632-88FD906EDC1BQ36603235-44288099-B1BF-4237-AD0A-AA4B6A951425Q36759690-EC2F086C-AEC7-44F6-96F9-A72133A40257Q36801193-04892AFA-50C7-4087-8E58-50029C9D5959Q36820532-289C15D7-CB6D-4330-B7A4-EEC866D80FCBQ37073640-21E1E530-D785-4062-A64F-C7E85E287074Q37122878-952C33D4-8EE0-4C4A-A87F-CBE575820F19Q37169517-1F6ACD00-0E45-476D-9A22-867270E96D8AQ37275565-EC73AB1D-A1A2-4C63-929A-497FAB8B3338Q37305724-BB051B91-9BE2-439E-9AED-71FD226B3D3AQ37313286-B6200582-363E-43D2-B7D1-BDADD3875F19Q37486159-54A1CAE8-EDF8-42ED-9ED5-8787FB19897CQ37493916-C36D295E-0C35-4B46-BE8A-25E10634D54AQ37967486-2EEA03BA-E2CC-4FCE-BEDD-D4C9CEE63966Q38366731-16556406-4FE7-46FF-B1A9-68A1D096B1F3Q38616332-ECDF5BA8-5FD0-4A11-A083-35897E88FD60Q38667018-D3756936-88B9-45DE-9017-F4B4B2D32526Q38936714-6D7D59A9-A83C-4DF7-AF38-CF9AAA4FB388Q39418677-AB169E4A-08C6-4FD4-B146-BA3D5FE0D35DQ40490536-C1FB989E-122C-48AC-B156-908FA77FC0D9Q40978479-40627A6C-FD64-4130-A7E9-D9851593FAACQ45074304-1ED09C4E-3B5D-413D-A021-5E5125DA8565Q47150076-C89FFC8A-00B1-481E-8737-1415DC61CBFCQ48070530-051CE573-8B57-4B33-BEB1-41C00C02A7A0Q48095261-248FD3D9-8221-4C6D-8CCD-4AD0485DEC69
P2860
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of CA125 in predicting ov ...... he epidemiological literature.
@en
Role of CA125 in predicting ov ...... he epidemiological literature.
@nl
type
label
Role of CA125 in predicting ov ...... he epidemiological literature.
@en
Role of CA125 in predicting ov ...... he epidemiological literature.
@nl
prefLabel
Role of CA125 in predicting ov ...... he epidemiological literature.
@en
Role of CA125 in predicting ov ...... he epidemiological literature.
@nl
P2860
P356
P1476
Role of CA125 in predicting ov ...... he epidemiological literature.
@en
P2093
Christopher G Lis
Digant Gupta
P2860
P2888
P356
10.1186/1757-2215-2-13
P577
2009-10-09T00:00:00Z
P5875
P6179
1048876690